Immune Cell Correlation Analysis. by Guolian Wu (21464168)

“…These findings provide potential diagnostic biomarkers and therapeutic targets for KD, warranting further validation in larger studies.</p></div>…”

GO Enrichment Analysis. by Guolian Wu (21464168)

“…These findings provide potential diagnostic biomarkers and therapeutic targets for KD, warranting further validation in larger studies.</p></div>…”

Differential Analysis. by Guolian Wu (21464168)

“…These findings provide potential diagnostic biomarkers and therapeutic targets for KD, warranting further validation in larger studies.</p></div>…”

GO Diagram. by Guolian Wu (21464168)

“…These findings provide potential diagnostic biomarkers and therapeutic targets for KD, warranting further validation in larger studies.</p></div>…”

Hub Genes. by Guolian Wu (21464168)

“…These findings provide potential diagnostic biomarkers and therapeutic targets for KD, warranting further validation in larger studies.</p></div>…”

PPI. by Guolian Wu (21464168)

“…These findings provide potential diagnostic biomarkers and therapeutic targets for KD, warranting further validation in larger studies.</p></div>…”

Download Data. by Guolian Wu (21464168)

“…These findings provide potential diagnostic biomarkers and therapeutic targets for KD, warranting further validation in larger studies.</p></div>…”

Heatmap. by Guolian Wu (21464168)

“…These findings provide potential diagnostic biomarkers and therapeutic targets for KD, warranting further validation in larger studies.</p></div>…”

Figure 2. by Guolian Wu (21464168)

“…These findings provide potential diagnostic biomarkers and therapeutic targets for KD, warranting further validation in larger studies.</p></div>…”

KEGG Enrichment Analysis. by Guolian Wu (21464168)

“…These findings provide potential diagnostic biomarkers and therapeutic targets for KD, warranting further validation in larger studies.</p></div>…”

Figure 1. by Guolian Wu (21464168)

“…These findings provide potential diagnostic biomarkers and therapeutic targets for KD, warranting further validation in larger studies.</p></div>…”

Gene Name to ID Conversion. by Guolian Wu (21464168)

“…These findings provide potential diagnostic biomarkers and therapeutic targets for KD, warranting further validation in larger studies.</p></div>…”

Bar Chart. by Guolian Wu (21464168)

“…These findings provide potential diagnostic biomarkers and therapeutic targets for KD, warranting further validation in larger studies.</p></div>…”

Filter Samples with p < 0.05. by Guolian Wu (21464168)

“…These findings provide potential diagnostic biomarkers and therapeutic targets for KD, warranting further validation in larger studies.</p></div>…”

KEGG Diagram. by Guolian Wu (21464168)

“…These findings provide potential diagnostic biomarkers and therapeutic targets for KD, warranting further validation in larger studies.</p></div>…”

Grouping and Sorting. by Guolian Wu (21464168)

“…These findings provide potential diagnostic biomarkers and therapeutic targets for KD, warranting further validation in larger studies.</p></div>…”

Violin Plot. by Guolian Wu (21464168)

“…These findings provide potential diagnostic biomarkers and therapeutic targets for KD, warranting further validation in larger studies.</p></div>…”

XCell Algorithm for Immune Cell Matrix. by Guolian Wu (21464168)

“…These findings provide potential diagnostic biomarkers and therapeutic targets for KD, warranting further validation in larger studies.</p></div>…”

Data Sheet 1_Treatment with pemafibrate ameliorates fatty liver index and atherogenic lipid profiles in Japanese patients with type 2 diabetes mellitus.pdf by Toru Suzuki (512729)

“…FLI (mean ± standard deviation: 68.1 ± 21.9 vs. 39.6 ± 25.0, P < 0.001), but not FIB-4 index as a marker of hepatic fibrosis (median [interquartile range]: 1.04 [0.78-1.39] vs. 1.01 [0.68-1.36], P = 0.909), was significantly decreased by treatment with pemafibrate for 12M, and the proportion of patients with metabolic dysfunction-associated SLD (MASLD) was significantly decreased from 92.3% (baseline) to 61.5% (12M).…”

Table 1_Association between DASH diet and metabolic syndrome in US adults: a cross-sectional study.xlsx by Jianing Liu (140090)

“…The subgroup analyses revealed that the inverse association between DASH score and MetS risk was more pronounced among women, Whites, high-income individuals, those with a college degree or higher, those who were physically active, and never smokers. Subsequently, we discovered that DASH levels are significantly negatively correlated with waist circumference (WC), fasting plasma glucose (FPG), triglycerides (TG), and systolic blood pressure (SBP), while exhibiting a positive correlation with high-density lipoprotein cholesterol (HDL-C) through RCS curves and linear regression.…”